Trastuzumab and fatigue Patient Reports February 11, 2012
Trastuzumab Side Effects Report #4844541-1
Trastuzumab side effect was reported by a Physician from UNITED STATES on Nov 30, 2005. Female patient, 49 years of age, weighting 197.0 lb, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: asthenia, cardiac failure congestive, cardiogenic shock, cardiomyopathy
, dilatation ventricular, dysphonia, ejection fraction decreased, fatigue, hypotension. Trastuzumab dosage: 191 MG QWK IV. During the same period patient was treated with BEVACIZUMAB, NIFEDIPINE, GREEN FOOD, ATIVAN, ORIGINS, PAXIL. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5526065-1
Trastuzumab side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Nov 08, 2007. Female patient, 41 years of age, was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: anorexia, dehydration, fatigue, febrile neutropenia, nausea
. Trastuzumab dosage: 8 MG/KG, SINGLE. During the same period patient was treated with CAPECITABINE, VINORELBINE. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5614458-3
Trastuzumab side effect was reported by a Physician from UNITED KINGDOM on Jan 21, 2008. Female patient was diagnosed with breast cancer metastatic and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: blood potassium decreased, blood urea increased, bone pain, dehydration, fatigue, guillain-barre syndrome
, hypotension, lethargy. Trastuzumab dosage: 4 MG/KG, 1/WEEK. During the same period patient was treated with PACLITAXEL, LAPATINIB, HYDROCHLOROTHIAZIDE, LOPERAMIDE HYDROCHLORIDE, PERCOCET, TELMISARTAN, TEMAZEPAM, ZOLEDRONIC ACID. Patient was hospitalized. Patient recovered.Trastuzumab Side Effects Report #5350007-5
Trastuzumab side effect was reported by a Physician from GERMANY on May 23, 2007. Female patient, weighting 176.4 lb, was diagnosed with breast cancer
and was treated with Trastuzumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aortic valve incompetence, aspartate aminotransferase increased, blood alkaline phosphatase increased, bone pain, conjunctivitis, fatigue, hypersensitivity. Trastuzumab dosage: 8 MG/KG, SINGLE. During the same period patient was treated with EPIRUBICIN, CYCLOPHOSPHAMIDE, DOCETAXEL. Patient died on 01/17/2007.
Trastuzumab and fatigue 